BlueSkeye AI
Blueskeye AI uses machine learning to objectively and automatically analyse face and voice data to interpret medically relevant expressed behaviour and help improve quality of life.
To create the most-used technology for ethical machine understanding of face and voice behaviour trusted to measure the mind through the use of ubiquitously available, affordable technology
- BlueskeyeAI has grown from 14 to 28 colleagues in the last year
- Secured £3.4m in venture capital funding
- Launched a new software development kit (SDK); B-Social in 2022
- Launched B-Automove to support car manufacturers with delivering their digital health and wellbeing plans in 2023
- Innovation grant
- Winner of Medilink Midlands Business awards
“We have received from Medilink, an Innovation Support Grant for consultancy to support our imminent clinical trial.
We also won the Medilink Midlands Innovation Award 2023 following our “One to Watch” award in 2022, both of which have raised our profile in key markets”
Michael Valstar, CEO, Blueskye AI